Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas
(Q69586028)
scientific article published on 01 May 1989
scientific article published on 01 May 1989
Language: